Profile
Krystof S.
Bankiewicz is the founder of Voyager Therapeutics, Inc. (founded in 2013) and Brain Neurotherapy Bio, Inc. (founded in 2018).
At Brain Neurotherapy Bio, Inc., he held the title of Chief Executive Officer from 2018 to 2024.
Currently, Dr. Bankiewicz is the Director-Interventional Neurology Center at The University of California, San Francisco.
Dr. Bankiewicz holds a doctorate degree from Uniwersytet Jagiellonski and Instytut Psychiatrii I Neurologii.
Krystof S. Bankiewicz active positions
| Companies | Position | Start |
|---|---|---|
The University of California, San Francisco
The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Former positions of Krystof S. Bankiewicz
| Companies | Position | End |
|---|---|---|
Brain Neurotherapy Bio, Inc.
Brain Neurotherapy Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Develops transformative neurological gene therapies that restore and preserve health and well-being | Chief Executive Officer | 2024-01-31 |
| VOYAGER THERAPEUTICS, INC. | Founder | - |
Training of Krystof S. Bankiewicz
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
The University of California, San Francisco
The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Uniwersytet Jagiellonski
Uniwersytet Jagiellonski Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Instytut Psychiatrii I Neurologii
Instytut Psychiatrii I Neurologii Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Voyager Therapeutics, Inc.
Voyager Therapeutics, Inc. BiotechnologyHealth Technology Develops gene therapies for fatal and debilitating diseases of the central nervous system | Health Technology |
Brain Neurotherapy Bio, Inc.
Brain Neurotherapy Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Develops transformative neurological gene therapies that restore and preserve health and well-being | Commercial Services |
- Stock Market
- Insiders
- Krystof S. Bankiewicz
















